Christopher Ehrlich

Christopher Ehrlich

Director/Board Member bei EFFECTOR THERAPEUTICS, INC.

Vermögen: 2 Mio $ am 31.03.2024

54 Jahre
Health Technology
Finance
Consumer Services

Profil

Christopher B.
Ehrlich
is the founder of Prostate Management Diagnostics, Inc. (founded in 2014) and holds the title of Director.
He is also the founder of AlgoRx Pharmaceuticals, Inc. Mr. Ehrlich's current jobs include being a Director at QuatRx Pharmaceuticals Co. (since 2004), Prolynx LLC (since 2022), and eFFECTOR Therapeutics, Inc. (since 2021).
He is also the Chief Operating Officer & Director at CERo Therapeutics Holdings, Inc. (since 2021).
Mr. Ehrlich's former jobs include being the Chief Executive Officer & Director at Locust Walk Acquisition Corp.
(2020-2021), Chief Executive Officer & Director at Phoenix Biotech Acquisition Corp., Director-Business Development at Genentech, Inc. (1997), Director at KAI Pharmaceuticals, Inc., Director at BioMimetic Therapeutics, Inc. (2004-2013), Director at Satori Pharmaceuticals, Inc., Director at Carbylan Therapeutics, Inc., Director at Invuity, Inc., Director at Solace Pharmaceuticals, Inc., Director at Xenon Pharmaceuticals, Inc., Director-Licensing & Business Development at Purdue Pharma LP (1998-1999), Director-Biotechnology Strategy Development at The Lek (1992-1994), Managing Director & General Partner at InterWest Partners LLC (2000-2013), Director at CVRx, Inc., Director-Venture Capital at The US Russia Investment Fund (1994-1996), and Director at Follica, Inc. He was also an Independent Director at Transcept Pharma, Inc. (2009-2013) and Senior MD & Head-Global Biopharma at Locust Walk Partners LLC (2013-2021).
Mr. Ehrlich's education includes an undergraduate degree from Dartmouth College (1992) and an MBA from Kellogg School of Management (1998).
Mr. Ehrlich is also the founder of AlgoRx Pharmaceuticals, Inc...

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
3,24%
05.04.2024 482 425 ( 3,24% ) 1 Mio $ 31.03.2024
29.02.2024 1 409 ( 0,04% ) 20 276 $ 31.03.2024

Aktive Positionen von Christopher Ehrlich

UnternehmenPositionBeginn
EFFECTOR THERAPEUTICS, INC. Director/Board Member 25.08.2021
Director/Board Member 20.09.2022
Founder 01.01.2014
Director/Board Member 01.10.2004
Alle aktiven Positionen von Christopher Ehrlich

Ehemalige bekannte Positionen von Christopher Ehrlich

UnternehmenPositionEnde
EFFECTOR THERAPEUTICS, INC. Chief Executive Officer 01.08.2021
Corporate Officer/Principal 01.01.2021
INVUITY INC Director/Board Member 01.01.2018
Director/Board Member 31.12.2013
Corporate Officer/Principal 01.01.2013
Sehen Sie sich die Erfahrung von Christopher Ehrlich im Detail an

Ausbildung von Christopher Ehrlich

Dartmouth College Undergraduate Degree
Kellogg School of Management Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Christopher Ehrlich im Detail an

Beziehungen

99

Beziehungen ersten Grades

25

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
XENON PHARMACEUTICALS INC.

Health Technology

CVRX, INC.

Health Technology

EFFECTOR THERAPEUTICS, INC.

Health Technology

Private Unternehmen20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Finance

Consumer Services

Health Technology

Commercial Services

Commercial Services

Finance

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Christopher Ehrlich